SCHEMBL1279834

SCHEMBL1279834

CCCC1COC(Cn2cncn2)(c2ccc(Oc3cc(Cl)ccc3F)cc2)O1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 17/20 0.64
HSP90AA1 P07900 2/20 0.64
NPSR1 Q6W5P4 1/20 0.64
THRB P10828 1/20 0.55
LMNA P02545 2/20 0.46
FYN P06241 2/20 0.46
CYP51A1 Q16850 2/20 0.46
NR1I2 O75469 1/20 0.46
PGR P06401 1/20 0.46
CHRM2 P08172 1/20 0.46
CHRM4 P08173 1/20 0.46
CHRM5 P08912 1/20 0.46
ADRA2A P08913 1/20 0.46
CHRM1 P11229 1/20 0.46
TSHR P16473 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46
CHRM3 P20309 1/20 0.46
DRD1 P21728 1/20 0.46
TBXA2R P21731 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1280631 0.94 CYP3A4 (0.63) CYP3A4HSP90AA1NPSR1THRBLMNA
SCHEMBL1279771 0.94 CYP3A4 (0.62) CYP3A4HSP90AA1NPSR1THRBLMNA
SCHEMBL1279696 0.92 HSP90AA1 (0.65) CYP3A4HSP90AA1NPSR1THRBLMNA
SCHEMBL1279370 0.88 CYP3A4 (0.61) CYP3A4HSP90AA1NPSR1THRBLMNA
SCHEMBL1280452 0.88 CYP3A4 (0.49) CYP3A4HSP90AA1NPSR1THRBLMNA
SCHEMBL9363260 0.87 HSP90AA1 (0.84) CYP3A4HSP90AA1NPSR1THRBLMNA
SCHEMBL1280044 0.86 HSP90AA1 (0.55) CYP3A4HSP90AA1NPSR1THRBLMNA
SCHEMBL1279477 0.84 HSP90AA1 (0.68) CYP3A4HSP90AA1NPSR1THRBLMNA
SCHEMBL1280022 0.84 HSP90AA1 (0.63) CYP3A4HSP90AA1NPSR1THRBLMNA
SCHEMBL9458123 0.84 CYP3A4 (0.67) CYP3A4HSP90AA1NPSR1THRBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2443109-A1 TRIAZOLE COMPOUNDS CARRYING A SULFUR SUBSTITUENT BASF SE (DE) 2012-04-25 EP disclosed
US-20120088663-A1 Triazole Compounds Carrying a Sulfur Substituent BASF SE (DE) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088663-A1 Triazole Compounds Carrying a Sulfur Substituent TST, STS, SQOR CYP3A4 39/4885HSP90AA1 3133/4885NPSR1 3019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.